{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T04:36:58Z","timestamp":1795149418831,"version":"4.10.3"},"reference-count":42,"publisher":"American Medical Association (AMA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Ophthalmol"],"published-print":{"date-parts":[[2024,6,1]]},"abstract":"<jats:sec>\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Despite widespread availability and consensus on its advantages for detailed imaging of geographic atrophy (GA), spectral-domain optical coherence tomography (SD-OCT) might benefit from automated quantitative OCT analyses in GA diagnosis, monitoring, and reporting of its landmark clinical trials.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To analyze the association between pegcetacoplan and consensus GA SD-OCT end points.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>\n                      This was a post hoc analysis of 11\u202f614 SD-OCT volumes from 936 of the 1258 participants in 2 parallel phase 3 studies, the Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (OAKS) and Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (DERBY). OAKS and DERBY were 24-month, multicenter, randomized, double-masked, sham-controlled studies conducted from August 2018 to July 2020 among adults with GA with total area 2.5 to 17.5 mm\n                      <jats:sup>2<\/jats:sup>\n                      on fundus autofluorescence imaging (if multifocal, at least 1 lesion \u22651.25 mm\n                      <jats:sup>2<\/jats:sup>\n                      ). This analysis was conducted from September to December 2023.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions<\/jats:title>\n                    <jats:p>Study participants received pegcetacoplan, 15 mg per 0.1-mL intravitreal injection, monthly or every other month, or sham injection monthly or every other month.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>The primary end point was the least squares mean change from baseline in area of retinal pigment epithelium and outer retinal atrophy in each of the 3 treatment arms (pegcetacoplan monthly, pegcetacoplan every other month, and pooled sham [sham monthly and sham every other month]) at 24 months. Feature-specific area analysis was conducted by Early Treatment Diabetic Retinopathy Study (ETDRS) regions of interest (ie, foveal, parafoveal, and perifoveal).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 936 participants, the mean (SD) age was 78.5 (7.22) years, and 570 participants (60.9%) were female. Pegcetacoplan, but not sham treatment, was associated with reduced growth rates of SD-OCT biomarkers for GA for up to 24 months. Reductions vs sham in least squares mean (SE) change from baseline of retinal pigment epithelium and outer retinal atrophy area were detectable at every time point from 3 through 24 months (least squares mean difference vs pooled sham at month 24, pegcetacoplan monthly: \u22120.86 mm\n                      <jats:sup>2<\/jats:sup>\n                      ; 95% CI, \u22121.15 to \u22120.57;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.001; pegcetacoplan every other month: \u22120.69 mm\n                      <jats:sup>2<\/jats:sup>\n                      ; 95% CI, \u22120.98 to \u22120.39;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.001). This association was more pronounced with more frequent dosing (pegcetacoplan monthly vs pegcetacoplan every other month at month 24: \u22120.17 mm\n                      <jats:sup>2<\/jats:sup>\n                      ; 95% CI, \u22120.43 to 0.08;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.17). Stronger associations were observed in the parafoveal and perifoveal regions for both pegcetacoplan monthly and pegcetacoplan every other month.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>These findings offer additional insight into the potential effects of pegcetacoplan on the development of GA, including potential effects on the retinal pigment epithelium and photoreceptors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial Registration<\/jats:title>\n                    <jats:p>\n                      ClinicalTrials.gov Identifiers:\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/study\/NCT03525600?id=NCT03525600&amp;amp;amp;rank=1&amp;amp;amp;tab=results\">NCT03525600<\/jats:ext-link>\n                      and\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/study\/NCT03525613?id=NCT03525613&amp;amp;amp;rank=1&amp;amp;amp;tab=results\">NCT03525613<\/jats:ext-link>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamaophthalmol.2024.1269","type":"journal-article","created":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T11:00:43Z","timestamp":1715252443000},"page":"548","source":"Crossref","is-referenced-by-count":37,"title":["Pegcetacoplan Treatment and Consensus Features of Geographic Atrophy Over 24 Months"],"prefix":"10.1001","volume":"142","author":[{"given":"Dun Jack","family":"Fu","sequence":"first","affiliation":[{"name":"National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital and University College London Institute of Ophthalmology, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pallavi","family":"Bagga","sequence":"additional","affiliation":[{"name":"National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital and University College London Institute of Ophthalmology, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunjan","family":"Naik","sequence":"additional","affiliation":[{"name":"National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital and University College London Institute of Ophthalmology, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Glinton","sequence":"additional","affiliation":[{"name":"National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital and University College London Institute of Ophthalmology, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Livia","family":"Faes","sequence":"additional","affiliation":[{"name":"National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital and University College London Institute of Ophthalmology, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"Liefers","sequence":"additional","affiliation":[{"name":"National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital and University College London Institute of Ophthalmology, London, United Kingdom"},{"name":"Department of Ophthalmology, Erasmus University Medical Center, Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosana","family":"Lima","sequence":"additional","affiliation":[{"name":"National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital and University College London Institute of Ophthalmology, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgina","family":"Wignall","sequence":"additional","affiliation":[{"name":"National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital and University College London Institute of Ophthalmology, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pearse A.","family":"Keane","sequence":"additional","affiliation":[{"name":"National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital and University College London Institute of Ophthalmology, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estelle","family":"Ioannidou","sequence":"additional","affiliation":[{"name":"National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital and University College London Institute of Ophthalmology, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Paula","family":"Ribeiro Reis","sequence":"additional","affiliation":[{"name":"National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital and University College London Institute of Ophthalmology, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"McKeown","sequence":"additional","affiliation":[{"name":"Apellis Pharmaceuticals, Waltham, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Scheibler","sequence":"additional","affiliation":[{"name":"Apellis Pharmaceuticals, Waltham, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praveen J.","family":"Patel","sequence":"additional","affiliation":[{"name":"National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital and University College London Institute of Ophthalmology, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismail","family":"Moghul","sequence":"additional","affiliation":[{"name":"National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital and University College London Institute of Ophthalmology, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolas","family":"Pontikos","sequence":"additional","affiliation":[{"name":"National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital and University College London Institute of Ophthalmology, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Balaskas","sequence":"additional","affiliation":[{"name":"National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital and University College London Institute of Ophthalmology, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"9827","key":"eoi240023r1","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1016\/S0140-6736(12)60282-7","article-title":"Age-related macular degeneration.","volume":"379","author":"Lim","year":"2012","journal-title":"Lancet"},{"issue":"12","key":"eoi240023r2","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.1097\/IAE.0000000000001258","article-title":"Geographic atrophy: semantic considerations and literature review.","volume":"36","author":"Schmitz-Valckenberg","year":"2016","journal-title":"Retina"},{"issue":"3","key":"eoi240023r3","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1001\/archopht.1973.01000050208006","article-title":"Drusen and disciform macular detachment and degeneration.","volume":"90","author":"Gass","year":"1973","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"eoi240023r4","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1167\/iovs.07-1132","article-title":"Report from the NEI\/FDA Ophthalmic Clinical Trial Design and Endpoints Symposium.","volume":"49","author":"Csaky","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"eoi240023r5","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1097\/IAE.0000000000001283","article-title":"Clinical endpoints for the study of geographic atrophy secondary to age-related macular degeneration.","volume":"36","author":"Sadda","year":"2016","journal-title":"Retina"},{"issue":"3","key":"eoi240023r6","first-page":"718","article-title":"In vivo fluorescence of the ocular fundus exhibits retinal pigment epithelium lipofuscin characteristics.","volume":"36","author":"Delori","year":"1995","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"eoi240023r7","first-page":"583","article-title":"Lipofuscin and melanin of human retinal pigment epithelium. fluorescence, enzyme cytochemical, and ultrastructural studies.","volume":"17","author":"Feeney","year":"1978","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"eoi240023r8","first-page":"478","article-title":"Fundus autofluorescence in age-related macular disease imaged with a laser scanning ophthalmoscope.","volume":"38","author":"von R\u00fcckmann","year":"1997","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"eoi240023r9","doi-asserted-by":"publisher","first-page":"3673","DOI":"10.1167\/iovs.12-10672","article-title":"Adaptive optics imaging of geographic atrophy.","volume":"54","author":"Gocho","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"eoi240023r10","doi-asserted-by":"publisher","first-page":"3253","DOI":"10.1167\/iovs.15-16431","article-title":"The project MACULA retinal pigment epithelium grading system for histology and optical coherence tomography in age-related macular degeneration.","volume":"56","author":"Zanzottera","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"suppl 1","key":"eoi240023r11","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1097\/IAE.0000000000001276","article-title":"Visualizing retinal pigment epithelium phenotypes in the transition to geographic atrophy in age-related macular degeneration.","volume":"36","author":"Zanzottera","year":"2016","journal-title":"Retina"},{"issue":"4","key":"eoi240023r12","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.ophtha.2017.09.028","article-title":"Consensus definition for atrophy associated with age-related macular degeneration on OCT: Classification of Atrophy report 3.","volume":"125","author":"Sadda","year":"2018","journal-title":"Ophthalmology"},{"issue":"3","key":"eoi240023r13","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.ophtha.2019.09.035","article-title":"Incomplete retinal pigment epithelial and outer retinal atrophy in age-related macular degeneration: Classification of Atrophy Meeting report 4.","volume":"127","author":"Guymer","year":"2020","journal-title":"Ophthalmology"},{"issue":"3","key":"eoi240023r14","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1001\/jamaophthalmol.2013.5799","article-title":"Geographic atrophy: a histopathological assessment.","volume":"132","author":"Bird","year":"2014","journal-title":"JAMA Ophthalmol"},{"issue":"6","key":"eoi240023r15","doi-asserted-by":"publisher","first-page":"3761","DOI":"10.1167\/iovs.10-7021","article-title":"Fundus autofluorescence and spectral-domain optical coherence tomography characteristics in a rapidly progressing form of geographic atrophy.","volume":"52","author":"Fleckenstein","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"eoi240023r16","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1016\/j.ophtha.2015.03.027","article-title":"Directional kinetics of geographic atrophy progression in age-related macular degeneration with foveal sparing.","volume":"122","author":"Lindner","year":"2015","journal-title":"Ophthalmology"},{"issue":"2","key":"eoi240023r17","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.sjopt.2014.03.008","article-title":"Fundus autofluorescence imaging: fundamentals and clinical relevance.","volume":"28","author":"Sepah","year":"2014","journal-title":"Saudi J Ophthalmol"},{"issue":"4","key":"eoi240023r18","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.ophtha.2016.12.002","article-title":"Imaging protocols in clinical studies in advanced age-related macular degeneration: recommendations from Classification of Atrophy Consensus Meetings.","volume":"124","author":"Holz","year":"2017","journal-title":"Ophthalmology"},{"issue":"3","key":"eoi240023r19","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1364\/BOE.8.001638","article-title":"The ecosystem that powered the translation of OCT from fundamental research to clinical and commercial impact.","volume":"8","author":"Swanson","year":"2017","journal-title":"Biomed Opt Express"},{"issue":"8","key":"eoi240023r20","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1016\/j.ophtha.2014.02.023","article-title":"Proposed lexicon for anatomic landmarks in normal posterior segment spectral-domain optical coherence tomography: the IN\u2022OCT consensus.","volume":"121","author":"Staurenghi","year":"2014","journal-title":"Ophthalmology"},{"issue":"9","key":"eoi240023r21","doi-asserted-by":"publisher","first-page":"3456","DOI":"10.1167\/iovs.17-22339","article-title":"Report from the NEI\/FDA Endpoints Workshop on Age-Related Macular Degeneration and Inherited Retinal Diseases.","volume":"58","author":"Csaky","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"eoi240023r22","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1167\/tvst.9.2.57","article-title":"Artificial intelligence algorithms for analysis of geographic atrophy: a review and evaluation.","volume":"9","author":"Arslan","year":"2020","journal-title":"Transl Vis Sci Technol"},{"issue":"1","key":"eoi240023r23","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.oret.2020.07.006","article-title":"Quantification of geographic atrophy using spectral domain OCT in age-related macular degeneration.","volume":"5","author":"Cleland","year":"2021","journal-title":"Ophthalmol Retina"},{"issue":"4","key":"eoi240023r24","doi-asserted-by":"publisher","DOI":"10.1016\/j.xops.2023.100325","article-title":"Reticular pseudodrusen: interreader agreement of evaluation on OCT imaging in age-related macular degeneration.","volume":"3","author":"Wu","year":"2023","journal-title":"Ophthalmol Sci"},{"issue":"10","key":"eoi240023r25","doi-asserted-by":"publisher","first-page":"e665","DOI":"10.1016\/S2589-7500(21)00134-5","article-title":"Clinically relevant deep learning for detection and quantification of geographic atrophy from optical coherence tomography: a model development and external validation study.","volume":"3","author":"Zhang","year":"2021","journal-title":"Lancet Digit Health"},{"issue":"4","key":"eoi240023r26","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1136\/bjo-2022-322672","article-title":"Deep-learning automated quantification of longitudinal OCT scans demonstrates reduced RPE loss rate, preservation of intact macular area and predictive value of isolated photoreceptor degeneration in geographic atrophy patients receiving C3 inhibition treatment.","volume":"108","author":"Fu","year":"2024","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"eoi240023r27","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/eye.2009.211","article-title":"Optical coherence tomography-based decision making in exudative age-related macular degeneration: comparison of time- vs spectral-domain devices.","volume":"24","author":"Cukras","year":"2010","journal-title":"Eye (Lond)"},{"issue":"10411","key":"eoi240023r28","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1016\/S0140-6736(23)01520-9","article-title":"Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials.","volume":"402","author":"Heier","year":"2023","journal-title":"Lancet"},{"issue":"1","key":"eoi240023r29","doi-asserted-by":"publisher","first-page":"15565","DOI":"10.1038\/s41598-022-19413-z","article-title":"Prediction of visual function from automatically quantified optical coherence tomography biomarkers in patients with geographic atrophy using machine learning.","volume":"12","author":"Balaskas","year":"2022","journal-title":"Sci Rep"},{"issue":"4","key":"eoi240023r30","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1159\/000330420","article-title":"Imaging geographic atrophy in age-related macular degeneration.","volume":"226","author":"G\u00f6bel","year":"2011","journal-title":"Ophthalmologica"},{"issue":"2","key":"eoi240023r32","doi-asserted-by":"publisher","DOI":"10.1016\/j.xops.2023.100274","article-title":"Biologically guided optimization of test target location for rod-mediated dark adaptation in age-related macular degeneration: Alabama study on early age-related macular degeneration 2 baseline.","volume":"3","author":"Owsley","year":"2023","journal-title":"Ophthalmol Sci"},{"issue":"9","key":"eoi240023r33","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1016\/S0161-6420(99)90340-8","article-title":"Enlargement of atrophy and visual acuity loss in the geographic atrophy form of age-related macular degeneration.","volume":"106","author":"Sunness","year":"1999","journal-title":"Ophthalmology"},{"issue":"10","key":"eoi240023r34","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1016\/S0161-6420(97)30079-7","article-title":"Visual function abnormalities and prognosis in eyes with age-related geographic atrophy of the macula and good visual acuity.","volume":"104","author":"Sunness","year":"1997","journal-title":"Ophthalmology"},{"issue":"9","key":"eoi240023r35","doi-asserted-by":"publisher","first-page":"3309","DOI":"10.1167\/iovs.04-0430","article-title":"Classification of fundus autofluorescence patterns in early age-related macular disease.","volume":"46","author":"Bindewald","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"eoi240023r36","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.ophtha.2010.08.018","article-title":"Progression of geographic atrophy in age-related macular degeneration imaged with spectral domain optical coherence tomography.","volume":"118","author":"Yehoshua","year":"2011","journal-title":"Ophthalmology"},{"issue":"2","key":"eoi240023r37","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/ng.3448","article-title":"A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants.","volume":"48","author":"Fritsche","year":"2016","journal-title":"Nat Genet"},{"issue":"1","key":"eoi240023r38","doi-asserted-by":"publisher","first-page":"7348","DOI":"10.1038\/s41598-018-25557-8","article-title":"Classical and alternative complement activation on photoreceptor outer segments drives monocyte-dependent retinal atrophy.","volume":"8","author":"Katschke","year":"2018","journal-title":"Sci Rep"},{"issue":"5","key":"eoi240023r39","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1097\/IAE.0000000000001392","article-title":"The pathophysiology of geographic atrophy secondary to age-related macular degeneration and the complement pathway as a therapeutic target.","volume":"37","author":"Boyer","year":"2017","journal-title":"Retina"},{"issue":"2","key":"eoi240023r40","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.ophtha.2019.07.011","article-title":"Complement C3 inhibitor pegcetacoplan for geographic atrophy secondary to age-related macular degeneration: a randomized phase 2 trial.","volume":"127","author":"Liao","year":"2020","journal-title":"Ophthalmology"},{"issue":"10","key":"eoi240023r41","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1001\/jamaophthalmol.2020.2914","article-title":"Progression of photoreceptor degeneration in geographic atrophy secondary to age-related macular degeneration.","volume":"138","author":"Pfau","year":"2020","journal-title":"JAMA Ophthalmol"},{"issue":"11","key":"eoi240023r42","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/j.oret.2022.05.030","article-title":"The effect of pegcetacoplan treatment on photoreceptor maintenance in geographic atrophy monitored by artificial intelligence-based OCT analysis.","volume":"6","author":"Riedl","year":"2022","journal-title":"Ophthalmol Retina"},{"key":"eoi240023r31","volume-title":"The Retina: The Anatomy","author":"Polyak","year":"1941"}],"container-title":["JAMA Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/articlepdf\/2818579\/jamaophthalmology_fu_2024_oi_240023_1718141444.37988.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T11:06:09Z","timestamp":1718881569000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/fullarticle\/2818579"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,1]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaophthalmol.2024.1269","relation":{},"ISSN":["2168-6165"],"issn-type":[{"value":"2168-6165","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,1]]}}}